THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI LAUNCHES EBOLA+ PROGRAMME
IMI has launched an ambitious programme to accelerate the development of vaccines and treatments against Ebola and related diseases. The first Call under the Ebola+ programme has a total budget of €280m.
- 26/11/2014 : Last slide of the day sums things up: #IMI2 builds on IMI1 & is open to ALL relevant partners http://t.co/yBn7AsF5PY
- 26/11/2014 : Want to get involved in IMI but not sure which route is best for you? CONTACT US and we'll talk it through!
- 26/11/2014 : A 4th option is to actually become a member of IMI.